10-Q: Hestia Insight Inc. Q2 2026 Financials Show Increased Losses

Sentiment:

Quarterly Report


Hestia Insight Inc. reported a net loss of $478,971 for the six months ended May 31, 2026, an improvement from the prior year's loss, but operating expenses significantly increased.

Capital raiseThe company states it is dependent on debt and equity financing to fund its operations.Management is making efforts to raise additional funding until an equity funding facility registration statement is in effect.The company will need to raise additional capital to fund operations and provide working capital.Future operations are dependent on the ability to secure additional financing, which may include the issuance of equity or debt securities, or obtaining credit facilities.
Worse than expectedOperating expenses increased significantly by $343,494 to $576,401 for the six months ended May 31, 2026, compared to $232,907 for the same period in 2025, primarily driven by increased officer compensation.Cash and cash equivalents decreased to $19,141 as of May 31, 2026, from $28,871 as of November 30, 2025, indicating a reduction in readily available funds.The company's accumulated deficit grew to $1,536,740 as of May 31, 2026, indicating continued unprofitability.Disclosure controls and procedures were deemed ineffective, raising concerns about the reliability of financial reporting and disclosures.

Summary

  • Hestia Insight Inc. reported a net loss of $478,971 for the six months ended May 31, 2026, compared to a net loss of $644,757 for the same period in 2025.
  • Total revenue for the six months ended May 31, 2026, was $16,000, an increase from $0 in the prior year period.
  • Operating expenses rose significantly to $576,401 for the six months ended May 31, 2026, from $232,907 in the prior year period, primarily due to increased officer compensation.
  • Cash and cash equivalents decreased to $19,141 as of May 31, 2026, from $28,871 as of November 30, 2025.
  • The company continues to rely on related party loans and shareholder financing to fund operations.
  • Disclosure controls and procedures were deemed ineffective due to limited resources and personnel.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing as negative due to significant operating losses, increased expenses, declining cash reserves, and ineffective disclosure controls, despite a slight increase in revenue and a reduction in net loss.

Positives

  • Revenue increased to $16,000 for the six months ended May 31, 2026, from $0 in the prior year period.
  • Net loss decreased to $478,971 for the six months ended May 31, 2026, from $644,757 in the prior year period.
  • Professional fees decreased by 43% to $35,828 for the six months ended May 31, 2026, compared to $62,688 in the prior year period.

Negatives

  • The company reported a net loss of $478,971 for the six months ended May 31, 2026.
  • Operating expenses increased by $343,494 to $576,401 for the six months ended May 31, 2026, primarily due to increased officer compensation.
  • Cash and cash equivalents decreased to $19,141 as of May 31, 2026.
  • The company has an accumulated deficit of $1,536,740 as of May 31, 2026.
  • Disclosure controls and procedures were found to be ineffective.

Risks

  • The company has not yet established an ongoing source of revenues sufficient to cover its operating costs and is dependent on debt and equity financing to fund its operations.
  • There can be no assurance that the company will be able to raise additional equity capital or be successful in the development and commercialization of its investments and services.
  • The company's failure to anticipate accurately the application of healthcare laws and regulations, or its other failure to comply, could create liability, result in adverse publicity, and otherwise negatively affect its business.
  • The company owns no patents and has not applied for or received patent protection, creating a risk that it will not be able to adequately protect its intellectual property rights.
  • The company's available cash is estimated to be insufficient to satisfy its cash requirements under current operating expectations, necessitating additional capital raises.
  • The inability to obtain additional capital may restrict the company's ability to grow and may reduce its ability to continue to conduct business operations.

Future Outlook

The company's future operations are dependent on its ability to secure additional financing. Capital requirements for the next twelve months relate to cash to pay salaries, consulting fees, and third-party professional services. The company estimates its available cash will be insufficient to satisfy its cash requirements under current operating expectations.

Management Comments

  • "The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and is dependent on debt and equity financing to fund its operations."
  • "Management of the Company is making efforts to raise additional funding until a registration statement relating to an equity funding facility is in effect."
  • "Ultimately, the Company will need to achieve profitable operations in order to continue as a going concern."
  • "We will need to raise additional capital to fund our operations and to provide working capital for our ongoing operations and obligations."

Industry Context

StockSavvy.ai notes that Hestia Insight Inc. operates in the AI-powered capital markets advisory and business consulting sector, focusing on emerging growth companies. The company's strategy involves guiding clients through the fundraising lifecycle and providing fractional C-suite services, with a strategic focus on healthcare and biotech sectors. The current financial report indicates significant operating losses and a reliance on external financing, which is common for early-stage companies in this capital-intensive advisory space.

Comparison to Industry Standards

  • No direct comparable companies or specific industry benchmarks were provided in the filing for comparison.
  • The company's revenue generation of $16,000 for the six-month period is significantly below typical revenue for established consulting firms in the AI or capital markets advisory space.
  • The substantial operating loss and accumulated deficit are indicative of a company in a development stage, which is not uncommon for startups in the technology and advisory sectors, but highlights the need for substantial future funding.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Disclosure Controls and ProceduresDisclosure controls and procedures were evaluated and found to be ineffective as of May 31, 2026, due to the company's limited resources and limited number of employees.2026-05-31Potential risk to the reliability of financial reporting and timely disclosure of material information.

Legal Proceedings

  • The company is not presently a party to any legal proceedings that, if determined adversely, would individually or taken together have a material adverse effect on its business, operating results, financial condition, or cash flows.

Related Party Transactions

  • As of May 31, 2026, the company owes $500,000 in officer payable to Edward Lee, Chief Executive Officer, for services rendered over the preceding six years.
  • The company has outstanding related party loan payables totaling $233,101 as of May 31, 2026, including various notes payable to ECL Capital Partners Corp. and Mr. Edward Lee with interest rates of 6.00% per annum.
  • A short-term loan of $16,670 from Mr. Edward Lee was outstanding as of May 31, 2026.

Stakeholder Impact

  • Shareholders face continued risk of investment loss due to the company's ongoing losses and dependence on future financing.
  • Employees may face uncertainty regarding job security given the company's precarious financial position and need for additional capital.
  • Creditors and suppliers may face risks related to the company's ability to meet its financial obligations, particularly given the significant liabilities and cash flow challenges.

Next Steps

  • The company needs to secure additional financing to fund operations and working capital.
  • Management is actively seeking additional funding through equity and debt financing.
  • The company must achieve profitable operations to continue as a going concern.

Key Dates

DateDescription
2024-01-01Start date for hsta:ECLJan2024NotePayableMember
2024-01-15Maturity date for $50,000 note payable to ECL Capital Partners Corp.
2024-06-24Grant date for stock option to Edward Lee
2024-06-24Grant date for stock option to Eugene Cha
2024-08-24Start date for hsta:ECLAugust2024NoteMember
2024-08-24Maturity date for $25,000 note payable to ECL Capital Partners Corp.
2025-02-16Start date for hsta:EdwardLeeFeb2025NotePayableMember
2025-02-17Maturity date for $25,000 note payable to ECL Capital Partners Corp.

Recommendation

sell

The company exhibits significant financial distress with increasing operating expenses, declining cash reserves, a growing accumulated deficit, and ineffective disclosure controls. While revenue has seen a slight increase and net loss has narrowed, the overall financial health remains precarious, and the company's future is heavily dependent on securing substantial additional financing, which carries significant execution risk.

Keywords

Hestia Insight Inc., 10-Q Filing, Quarterly Report, AI Capital Markets, Fundraising Solutions, Healthcare Consulting, Biotech Advisory, Financial Statements

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.